History of Bayer Pharmaceuticals

Bayer Pharmaceuticals, founded in 1863 in Barmen, Germany, by Friedrich Bayer and Johann Friedrich Weskott, has a rich history marked by significant contributions to the pharmaceutical industry. Originally known for producing synthetic dyes, Bayer transitioned to pharmaceuticals with the discovery of acetylsalicylic acid (ASA) in 1897, marketed under the name Aspirin. Aspirin became one of the world's most widely used medications and laid the foundation for Bayer's pharmaceutical success.

Throughout the 20th and 21st centuries, Bayer expanded its pharmaceutical portfolio through groundbreaking research and strategic acquisitions. In 1925, Bayer merged with several other chemical companies to form IG Farben, but it was re-established as an independent entity after World War II. The company continued to innovate, developing antibiotics, cardiovascular treatments, and other significant pharmaceutical products.

In recent decades, Bayer Pharmaceuticals has focused on research and development across a wide range of therapeutic areas, including cardiology, oncology, women's health, and hematology. Bayer has also made notable acquisitions, such as the purchase of Schering AG in 2006, which expanded its footprint in the pharmaceutical industry. Today, Bayer Pharmaceuticals remains a global leader in healthcare, committed to advancing science for a better life through its innovative medicines and patient-focused solutions.